---
title: "Keros Therapeutics controller, VP finance Annita Tanini files initial beneficial ownership statement"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295840055.md"
description: "Annita Tanini, Corporate Controller and VP of Finance at Keros Therapeutics, filed a Form 3 disclosing beneficial ownership. The filing reports 46,368 common shares held directly, along with employee stock options covering 71,100 shares with exercise prices ranging from $15.52 to $70.93."
datetime: "2026-08-13T20:15:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295840055.md)
  - [en](https://longbridge.com/en/news/295840055.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295840055.md)
generator: "portal-rs"
---

# Keros Therapeutics controller, VP finance Annita Tanini files initial beneficial ownership statement

-   Keros Therapeutics corporate controller and VP of finance Annita Tanini filed a Form 3 disclosing 46,368 common shares. \* Filing also reports employee stock options covering 71,100 shares, with exercise prices from $15.52 to $70.93. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Keros Therapeutics Inc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002146784-26-000002), on August 13, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [KROS.US](https://longbridge.com/en/quote/KROS.US.md)

## Related News & Research

- [Share Buyback Program Approved by Keros Therapeutics (NASDAQ:KROS) Board of Directors](https://longbridge.com/en/news/298526564.md)
- [Keros Therapeutics launches $5 million share buyback program](https://longbridge.com/en/news/298359108.md)
- [Keros Therapeutics director Jean Jacques Bieneaime acquires USD 10,270 in common shares](https://longbridge.com/en/news/296395349.md)
- [Keros Therapeutics names Annita Tanini interim CFO as Keith Regnante resigns](https://longbridge.com/en/news/293513881.md)
- [Keros Therapeutics director Charles W. Newton sells 551 common shares worth $5,675.3](https://longbridge.com/en/news/296531453.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**